MOPD Satellite Symposium: Clinical Advances and New Insights in the Management of Pediatric Atopic Dermatitis

Clinical Advances and New Insights in the Management of Pediatric Atopic Dermatitis

MOPD Satellite Symposium

Monday, October 5 | 7:00pm – 8:30pm CDT

Review the Educational Primer on Clinical Advances and New Insights in the Management of Pediatric Atopic Dermatitis

CME/CE Educational Primer

Educational Primer Links without CME/CE Credits

Agenda

  1. Opening remarks and pre-survey - Lawrence Schachner, MD
  2. Review of Diagnosis and Management Strategies for AD - Mercedes Gonzalez, MD
    1. Practical diagnosis of pediatric AD: different diagnosis, clinical presentation, and practical AD
      assessment tools 
    2. Review of non-pharmacologic strategies for pediatric AD including bathing and skin cleaning, use of 
      moisturizers, wet dressings and patient education. 
  1. New and Emerging Therapies for AD - Lawrence Schachner, MD
    • Conventional therapies for pediatric AD
      • Topical corticosteroids, topical calcineurin inhibitors, traditional systemic agents 
      • Efficacy and safety 
    • New and emerging agents for AD - evidence on the pediatric population
      • Crisaborole, dupilumab, topical JAK inhibitors, and IL inhibitors
      • Efficacy and safety
    • Advances in the understanding of AD pathophysiology
      •   The role of inflammation, skin barrier dysfunction, and JAK/STAT pathway
  2. Applying the evidence to practice: interactive patient cases on AD diagnosis and management - Fernanda Schmidt, MD & Mercedes Gonzalez, MD
    1. Case 1 - Mild AD
      1. Topical therapy choices and strategies for prevention 
    2. Case 2 - Severe AD
      1. Systemic therapies and disease management 
    3. Case 3 - Moderate-Severe AD (infant)
      1. Clinical diagnosis, risk factors, AD pathogenesis, AD and food allergies 
  3. Conclusions, Q&A, and post-survey

FREE CME/CE SATELLITE SYMPOSIUM

*This symposium is neither sponsored nor endorsed by the American Academy of Pediatrics

Educational Objectives

Identify AD based on the evaluation of clinical characteristics specific to infants, children, and adolescents


Examine the efficacy and safety of current non-pharmacological and pharmacological treatments for AD patients across the age spectrum


Define the rationale and mechanism of action for the use of new and emerging agents, including crisaborole, dupilumab, and oral JAK inhibitors in the management of AD


Develop individualized treatment plans for pediatric patients with AD based on the efficacy and safety of current and new agents, treatment recommendations, and patient and caregiver preferences

View Accreditation

Faculty

Lawrence Schachner, MD
Professor in the Department of Dermatology, Professor of Pediatrics, and Co-Director of the Division of Pediatric Dermatology at the University of Miami, Miller School of Medicine. He is also Chair Emeritus of the Department of Dermatology and the Stiefel Chair
Read More
Mercedes Gonzalez, MD
Medical Director, Pediatric Dermatology of Miami
Assistant Professor, University of Miami Miller School of Medicine,
Dr. Phillip Frost Department of Dermatology and Herbert Wertheim College of Medicine
Read More
Fernanda Schmidt, MD
Assistant Professor
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine
Read More
This program is supported by an independent medical educational grant from Pfizer, Inc.

This symposium is neither sponsored nor endorsed by the American Academy of Pediatrics